
Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of product candidates derived from its lipid-crystal nano-particle, or cochleate, delivery technology platform. The firm's pipeline includes MAT2203, MAT2501 and others. Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of product candidates derived from its lipid-crystal nano-particle, or cochleate, delivery technology platform. The firm's pipeline includes MAT2203, MAT2501 and others.
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.01 | -1.13636363636 | 0.88 | 1.1899 | 0.8323 | 1103938 | 0.94496747 | CS |
4 | 0.1039 | 13.5621981465 | 0.7661 | 1.1899 | 0.73 | 576296 | 0.88475159 | CS |
12 | 0.3042 | 53.7645811241 | 0.5658 | 1.1899 | 0.4748 | 267476 | 0.82576569 | CS |
26 | 0.29 | 50 | 0.58 | 1.43 | 0.4748 | 349733 | 0.7238569 | CS |
52 | -7.205 | -89.226006192 | 8.075 | 9.6 | 0.4748 | 477647 | 4.01599363 | CS |
156 | -36.045 | -97.6432344575 | 36.915 | 47 | 0.4748 | 1328287 | 20.09559526 | CS |
260 | -39.63 | -97.8518518519 | 40.5 | 111 | 0.4748 | 1644725 | 37.85796058 | CS |
Symbol | Price | Vol. |
---|---|---|
RYDERyde Group Ltd | $ 0.4467 (153.23%) | 566.88M |
DNNDenison Mines Corp | $ 1.83 (0.00%) | 198.97M |
SOXSDirexion Daily Semiconductor Bear 3X Shares New | $ 9.35 (-0.95%) | 122.78M |
SOXLDirexion Daily Semiconductor Bull 3X Shares | $ 21.61 (0.89%) | 113.89M |
TSLZT Rex 2X Inverse Tesla Daily Target ETF | $ 1.6599 (-3.21%) | 91.3M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.